New pathway towards treatments for inflammatory diseases

A molecule thought to play a key role in some inflammatory diseases can be switched off by two widely used medicines, new research has shown. Scientists have identified a new biochemical pathway that can be controlled using metformin – a medicine used by diabetics to control blood sugar levels – and salicylate – the main ingredient in aspirin.